Sharma Amit serves as Executive at Checkpoint Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Sharma Amit has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 14, 2024 involved receiving (via award) 32,051 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 14, 2024 | CKPT | $0 | Award | 32,051 | $N/A | Discretionary |
Sharma Amit currently holds 82,051 shares of Checkpoint Therapeutics, Inc. (CKPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharma Amit has been a net neutral trader of CKPT stock. They have purchased $0 and sold $0 worth of shares.
Sharma Amit's most recent insider trade was on May 14, 2024, when they sold 32,051 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted